Case Study
Accumulation Phase

HM Sampoerna: Indonesia’s Tobacco Value Trap or Accumulation Opportunity?

Why This Name Matters Right Now

HM Sampoerna is Indonesia’s largest cigarette manufacturer and a 93%-owned subsidiary of Philip Morris International. The stock has been in a multi-year decline from its 2017 highs, driven by excise tax hikes, market share losses to cheaper competitors, and ESG-related selling. At IDR 605, it trades at a fraction of its historical valuations. The Accumulation phase reading suggests that the selling may finally be exhausted and that value-oriented capital is beginning to position.

Tobacco in Indonesia is unlike tobacco anywhere else in the world. The country has over 70 million smokers, one of the highest male smoking rates globally, and a regulatory environment that is permissive by international standards. Understanding HMSP requires understanding Indonesia’s unique relationship with tobacco, particularly the kretek (clove cigarette) that dominates the market.

The Excise Tax Squeeze

The primary driver of HMSP’s decline has been a sustained excise tax hike cycle. The Indonesian government has raised tobacco excise taxes annually, often by double-digit percentages, compressing margins and forcing manufacturers to absorb part of the increase rather than pass it fully to consumers. For Sampoerna, which operates in the machine-made kretek segment where price sensitivity is high, the margin impact has been severe.

Market Share Battle

HMSP has been losing market share to hand-rolled kretek manufacturers (like Gudang Garam and Djarum) and smaller players who operate in lower excise tier brackets. The tiered excise system means that smaller manufacturers pay lower tax rates, giving them a structural pricing advantage. Sampoerna, as the largest player, sits in the highest tier and faces the heaviest tax burden.

Philip Morris has been trying to address this through product innovation, including heated tobacco products (IQOS) and lower-tier brand launches. The heated tobacco segment is still nascent in Indonesia, but it represents a potential growth avenue if regulation supports it. The challenge is that Indonesia’s regulatory framework for heated tobacco is still evolving, and excise treatment remains uncertain.

Why Accumulation Could Be the Right Call

The Accumulation reading makes sense when you consider the valuation floor. At 12x earnings and an 8% dividend yield, HMSP is pricing in significant further deterioration. If that deterioration does not materialise, if excise hikes moderate, if market share stabilises, if IQOS gains traction, the re-rating potential is substantial. Accumulation phases in deeply de-rated stocks often precede significant recoveries precisely because expectations are so low that even modest improvement triggers buying.

The Philip Morris ownership adds a dimension of stability. PMI is committed to Indonesia as one of its largest markets globally, and it has the financial resources and product pipeline to support Sampoerna through the transition. The high dividend payout rate also suggests that PMI is using Sampoerna as a cash-generating asset, which supports continued distributions to minority shareholders.

The ESG Dimension

ESG exclusions have been a significant source of selling pressure on HMSP. Global funds with tobacco exclusion policies have been forced sellers regardless of valuation, and that mechanical selling has contributed to the multi-year decline. The positive interpretation is that most of the ESG-driven selling is behind us: funds that needed to exit have largely done so. The remaining shareholder base is more likely to be value-oriented and tobacco-tolerant, which creates a firmer floor.

The Bottom Line

HMSP is one of the most polarising names on the IDX. The Accumulation phase reading suggests the worst of the selling may be over, but the structural headwinds from excise taxes and market share loss are real and ongoing. This is a name for investors with a contrarian disposition and a time horizon measured in years. The 8% dividend yield pays you to wait, and the PMI backing provides a floor on franchise value. But the transition from Accumulation to Markup requires a catalyst, and that catalyst, likely excise moderation or IQOS traction, has not yet arrived. Patience required.